# Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression

> **NCT07522242** · PHASE2 · RECRUITING · sponsor: **Laboratoires Thea** · enrollment: 200 (estimated)

## Conditions studied

- Myopia

## Interventions

- **DRUG:** T10430 lower dose
- **DRUG:** T10430 middle dose
- **DRUG:** T10430 higher dose
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT07522242
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-21
- **Primary completion:** 2027-11
- **Final completion:** 2027-11
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07522242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07522242, "Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT07522242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*